Diabetes Toolkit at Discharge

Last updated: May 20, 2025
Sponsor: Northwestern University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetes Mellitus, Type 1

Diabetes Prevention

Diabetes And Hypertension

Treatment

DM Discharge Toolkit

Clinical Study ID

NCT05663931
STU00216291
  • Ages 18-90
  • All Genders

Study Summary

The purpose of this randomized clinical trial is to implement the DM Discharge Toolkit into hospital discharge and assess the effect of the DM Discharge Toolkit on patients newly requiring insulin.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • English speaking patients

  • 18 years of age and older

  • Expected survival >90 days

  • Need for new insulin at time of hospital discharge

Exclusion

Exclusion Criteria:

  • Patients with the inability to give informed consent

  • Non-English speaking

  • Not diagnosed with diabetes

  • Not been newly prescribed insulin

Study Design

Total Participants: 120
Treatment Group(s): 1
Primary Treatment: DM Discharge Toolkit
Phase:
Study Start date:
January 10, 2023
Estimated Completion Date:
September 01, 2025

Study Description

This study is a randomized controlled trial with a parallel group design of up to 120 study participants in a 1:1 ratio to receive either current standard of care discharge DM training (control) or current standard of care discharge DM training and the DM Discharge Toolkit (intervention) before or immediately after being sent home to assume self-DM care with insulin.

Connect with a study center

  • Northwestern Memorial Hospital

    Chicago, Illinois 60611
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.